30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

CalciMedica Inc (CALC)

Track

The most recent insider trading activity occurred on September 18, 2025. Chief Business Officer Eric W. Roberts made multiple significant buy transactions totaling over $100,000 in August and September 2025. Chief Medical Officer Sudarshan Hebbar and Chief Scientific Officer Kenneth A. Stauderman also engaged in buying and selling activities during July and August 2025.
Stock chart
Ticker: CALC Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Roberts Eric W
CHIEF BUSINESS OFFICER
1 purchase — total 7,675 USD
Buy 18 Sep 2025
Value US$2,248,588.70 | Price 143.06 | Shares 92,980
Buy 15 Sep 2025
Value US$4,615,044.26 | Price 120.09 | Shares 27,868
Buy 12 Sep 2025
Value US$15,600.00 | Price 3.12 | Shares 5,000
Buy 9 Sep 2025
Value US$7,377.64 | Price 3.15 | Shares 2,343
Buy 29 Aug 2025
Value US$2,192.00 | Price 2.74 | Shares 800
Buy 28 Aug 2025
Value US$26,339.60 | Price 2.86 | Shares 9,200
Buy 21 Aug 2025
Value US$9,797.14 | Price 2.79 | Shares 3,508
Buy 20 Aug 2025
Value US$5,440.00 | Price 2.72 | Shares 2,000
Buy 19 Aug 2025
Value US$26,961.92 | Price 2.82 | Shares 9,563
Buy 19 Aug 2025
Value US$2,790.00 | Price 2.79 | Shares 1,000
Buy 15 Aug 2025
Value US$14,708.73 | Price 2.90 | Shares 5,076
Buy 15 Aug 2025
Value US$12,266.86 | Price 2.79 | Shares 4,392
Buy 14 Aug 2025
Value US$4,094.64 | Price 2.59 | Shares 1,584
Buy 28 Jul 2025
Value US$3,960.00 | Price 3.96 | Shares 1,000
Sale 25 Jul 2025
Value US$3,650.00 | Price 3.65 | Shares 1,000
Buy 22 Jul 2025
Value US$5,662.50 | Price 3.78 | Shares 1,500
Buy 21 Jul 2025
Value US$5,055.00 | Price 3.37 | Shares 1,500
Buy 21 Jul 2025
Value US$3,400.00 | Price 3.40 | Shares 1,000
Buy 18 Jul 2025
Value US$12,915.00 | Price 2.87 | Shares 4,500
Buy 18 Jul 2025
Value US$5,760.00 | Price 2.88 | Shares 2,000
Buy 14 Jul 2025
Value US$15,809.95 | Price 2.43 | Shares 6,500
Buy 14 Jul 2025
Value US$6,175.00 | Price 2.47 | Shares 2,500
Buy 9 Jul 2025
Value US$8,023.50 | Price 1.60 | Shares 5,000
Buy 1 Jul 2025
Value US$1,850.00 | Price 1.85 | Shares 1,000
Buy 26 Jun 2025
Value US$6,482.70 | Price 1.44 | Shares 4,500
Buy 26 Jun 2025
Value US$3,005.00 | Price 1.50 | Shares 2,000
Buy 11 Jun 2025
Value US$9,250.00 | Price 1.85 | Shares 5,000
Buy 6 Jun 2025
Value US$8,875.00 | Price 1.78 | Shares 5,000
Buy 5 Jun 2025
Value US$8,670.00 | Price 1.70 | Shares 5,100
Buy 30 May 2025
Value US$1,690.00 | Price 1.69 | Shares 1,000
Buy 6 Dec 2024
Value US$12,720.00 | Price 2.65 | Shares 4,800
Buy 1 Nov 2024
Value US$3,288.75 | Price 3.75 | Shares 877
Buy 1 Nov 2024
Value US$325,751.25 | Price 3.75 | Shares 86,867
Buy 1 Nov 2024
Value US$3,288.75 | Price 3.75 | Shares 877
Buy 1 Nov 2024
Value US$325,751.25 | Price 3.75 | Shares 86,867
Buy 1 Nov 2024
Value US$75,000.00 | Price 3.75 | Shares 20,000
Buy 1 Nov 2024
Value US$75,000.00 | Price 3.75 | Shares 20,000
Buy 1 Nov 2024
Value US$199,998.75 | Price 3.75 | Shares 53,333
Buy 1 Nov 2024
Value US$199,998.75 | Price 3.75 | Shares 53,333
Buy 27 Aug 2024
Value US$4,189.80 | Price 4.19 | Shares 1,000
Buy 23 Aug 2024
Value US$200,826.00 | Price 3.72 | Shares 54,000
Buy 23 Aug 2024
Value US$10,710.00 | Price 3.57 | Shares 3,000
Buy 23 Aug 2024
Value US$7,157.00 | Price 3.58 | Shares 2,000
Buy 21 Aug 2024
Value US$20,200.00 | Price 4.04 | Shares 5,000
Buy 28 Jun 2024
Value US$180,498.56 | Price 3.52 | Shares 51,278
Buy 27 Jun 2024
Value US$27,304.66 | Price 3.23 | Shares 8,443
Buy 27 Jun 2024
Value US$16,100.00 | Price 3.22 | Shares 5,000
Buy 2 Apr 2024
Value US$12,690.60 | Price 3.90 | Shares 3,254
Buy 1 Apr 2024
Value US$2,909.40 | Price 3.90 | Shares 746
Buy 23 Jan 2024
Value US$106,410.29 | Price 3.70 | Shares 28,744
Buy 23 Jan 2024
Value US$14,511.84 | Price 3.70 | Shares 3,920
Buy 23 Jan 2024
Value US$48,807.17 | Price 3.70 | Shares 13,184
Buy 23 Jan 2024
Value US$188,920.46 | Price 3.70 | Shares 51,032
Buy 23 Jan 2024
Value US$719,935.34 | Price 3.70 | Shares 194,472
Buy 23 Jan 2024
Value US$535,590.55 | Price 3.70 | Shares 144,676
Buy 23 Jan 2024
Value US$900,903.91 | Price 3.70 | Shares 243,356
Buy 23 Jan 2024
Value US$106,410.29 | Price 3.70 | Shares 28,744
Buy 23 Jan 2024
Value US$14,511.84 | Price 3.70 | Shares 3,920
Buy 23 Jan 2024
Value US$48,807.17 | Price 3.70 | Shares 13,184
Buy 23 Jan 2024
Value US$188,920.46 | Price 3.70 | Shares 51,032
Buy 23 Jan 2024
Value US$719,935.34 | Price 3.70 | Shares 194,472
Buy 23 Jan 2024
Value US$535,590.55 | Price 3.70 | Shares 144,676
Buy 23 Jan 2024
Value US$900,903.91 | Price 3.70 | Shares 243,356
Buy 11 Dec 2023
Value US$1,669.80 | Price 3.30 | Shares 506
Buy 7 Nov 2023
Value US$6,680.00 | Price 3.34 | Shares 2,000
Buy 6 Nov 2023
Value US$7,488.00 | Price 3.12 | Shares 2,400
Buy 6 Nov 2023
Value US$7,614.75 | Price 3.12 | Shares 2,440
Buy 3 Nov 2023
Value US$98,600.40 | Price 2.74 | Shares 36,000
Buy 3 Nov 2023
Value US$31,845.92 | Price 2.83 | Shares 11,249
Buy 3 Nov 2023
Value US$10,249.00 | Price 2.77 | Shares 3,700
Buy 3 Nov 2023
Value US$15,827.86 | Price 2.70 | Shares 5,860
Buy 3 Nov 2023
Value US$8,960.00 | Price 2.80 | Shares 3,200
Buy 3 Nov 2023
Value US$14,250.00 | Price 2.85 | Shares 5,000
Buy 25 Aug 2023
Value US$2,340.48 | Price 3.18 | Shares 736
Buy 22 Aug 2023
Value US$2,334.78 | Price 3.27 | Shares 714
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-22 2025-09-18 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
92,980 +21.0%
143.06
US$2,248,589 		92,980 +21.0% 143.06 US$2,248,589
2025-09-17 2025-09-15 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
27,868 +41.4%
120.09
US$4,615,044 		27,868 +41.4% 120.09 US$4,615,044
2025-09-15 2025-09-12 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
31,051 +23.0%
157.89
US$2,061,742 		31,051 +23.0% 157.89 US$2,061,742
2025-09-11 2025-09-09 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
2,343 +3.3%
3.15
US$7,378 		2,343 +3.3% 3.15 US$7,378
2025-09-02 2025-08-29 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
800 +1.1%
2.74
US$2,192 		800 +1.1% 2.74 US$2,192
2025-09-02 2025-08-28 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
9,200 +15.1%
2.86
US$26,340 		9,200 +15.1% 2.86 US$26,340
2025-08-25 2025-08-21 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
3,508 +6.1%
2.79
US$9,797 		3,508 +6.1% 2.79 US$9,797
2025-08-21 2025-08-20 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
2,000 +3.6%
2.72
US$5,440 		2,000 +3.6% 2.72 US$5,440
2025-08-21 2025-08-19 B Purchase
4.2
Hebbar Sudarshan

Chief Medical Officer

Officer
9,563 +18.4%
2.82
US$26,962 		9,563 +18.4% 2.82 US$26,962
2025-08-21 2025-08-19 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
1,000 +1.8%
2.79
US$2,790 		1,000 +1.8% 2.79 US$2,790
2025-08-19 2025-08-15 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
5,076 +10.3%
2.90
US$14,709 		5,076 +10.3% 2.90 US$14,709
2025-08-18 2025-08-15 B Purchase
4.2
Hebbar Sudarshan

Chief Medical Officer

Officer
4,392 +9.2%
2.79
US$12,267 		4,392 +9.2% 2.79 US$12,267
2025-08-18 2025-08-14 B Purchase
4.2
Hebbar Sudarshan

Chief Medical Officer

Officer
1,584 +3.4%
2.59
US$4,095 		1,584 +3.4% 2.59 US$4,095
2025-07-29 2025-07-28 B Purchase
2.8
Stauderman Kenneth A.

Chief Scientific Officer

Officer
1,000 +8.4%
3.96
US$3,960 		1,000 +8.4% 3.96 US$3,960
2025-07-29 2025-07-25 S Sale
2.8
Stauderman Kenneth A.

Chief Scientific Officer

Officer
1,000 -100.0%
3.65
US$3,650 		1,000 -100.0% 3.65 US$3,650
2025-07-23 2025-07-22 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
1,500 +3.1%
3.78
US$5,662 		1,500 +3.1% 3.78 US$5,662
2025-07-22 2025-07-21 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
1,500 +3.2%
3.37
US$5,055 		1,500 +3.2% 3.37 US$5,055
2025-07-21 2025-07-21 B Purchase
2.4
Leheny A. Rachel

CHIEF EXECUTIVE OFFICER

Executive Director Large shareholder
1,000 +40.0%
3.40
US$3,400 		1,000 +40.0% 3.40 US$3,400
2025-07-18 2025-07-18 B Purchase
2.9
WILSON ROBERT N
Non-Executive Director
4,500 +1.1%
2.87
US$12,915 		4,500 +1.1% 2.87 US$12,915
2025-07-18 2025-07-18 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
2,000 +4.5%
2.88
US$5,760 		2,000 +4.5% 2.88 US$5,760
2025-07-16 2025-07-14 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
6,500 +17.2%
2.43
US$15,810 		6,500 +17.2% 2.43 US$15,810
2025-07-15 2025-07-14 B Purchase
2.4
Leheny A. Rachel

CHIEF EXECUTIVE OFFICER

Executive Director Large shareholder
2,500 +inf%
2.47
US$6,175 		2,500 +inf% 2.47 US$6,175
2025-07-10 2025-07-09 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
5,000 +15.2%
1.60
US$8,024 		5,000 +15.2% 1.60 US$8,024
2025-07-02 2025-07-01 B Purchase
2.8
Stauderman Kenneth A.

Chief Scientific Officer

Officer
1,000 +inf%
1.85
US$1,850 		1,000 +inf% 1.85 US$1,850
2025-06-27 2025-06-26 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
4,500 +15.9%
1.44
US$6,483 		4,500 +15.9% 1.44 US$6,483
2025-06-26 2025-06-26 B Purchase
3.6
Bardin Stephen

Chief Financial Officer

Officer
2,000 +200.0%
1.50
US$3,005 		2,000 +200.0% 1.50 US$3,005
2025-06-13 2025-06-11 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
5,000 +21.4%
1.85
US$9,250 		5,000 +21.4% 1.85 US$9,250
2025-06-09 2025-06-06 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
5,000 +27.3%
1.78
US$8,875 		5,000 +27.3% 1.78 US$8,875
2025-06-09 2025-06-05 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
5,100 +38.6%
1.70
US$8,670 		5,100 +38.6% 1.70 US$8,670
2025-06-03 2025-05-30 B Purchase
3.6
Bardin Stephen

Chief Financial Officer

Officer
1,000 +2.5%
1.69
US$1,690 		1,000 +2.5% 1.69 US$1,690
2024-12-06 2024-12-06 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
4,800 +15.1%
2.65
US$12,720 		4,800 +15.1% 2.65 US$12,720
2024-11-05 2024-11-01 B Purchase
0.6
Sanderling Venture Partners VI Co Investment Fund LP
Large shareholder
877 +4.1%
3.75
US$3,289 		877 +4.1% 3.75 US$3,289
2024-11-05 2024-11-01 B Purchase
0.6
Sanderling Venture Partners VI Co Investment Fund LP
Large shareholder
86,867 +11.9%
3.75
US$325,751 		86,867 +11.9% 3.75 US$325,751
2024-11-05 2024-11-01 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
877 +4.1%
3.75
US$3,289 		877 +4.1% 3.75 US$3,289
2024-11-05 2024-11-01 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
86,867 +11.9%
3.75
US$325,751 		86,867 +11.9% 3.75 US$325,751
2024-11-05 2024-11-01 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
20,000 +170.7%
3.75
US$75,000 		20,000 +170.7% 3.75 US$75,000
2024-11-01 2024-11-01 B Purchase
2.4
Leheny A. Rachel

CHIEF EXECUTIVE OFFICER

Executive Director Large shareholder
20,000 +18.0%
3.75
US$75,000 		20,000 +18.0% 3.75 US$75,000
2024-11-01 2024-11-01 B Purchase
2.9
WILSON ROBERT N
Non-Executive Director
53,333 +14.6%
3.75
US$199,999 		53,333 +14.6% 3.75 US$199,999
2024-11-01 2024-11-01 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
53,333 +47.9%
3.75
US$199,999 		53,333 +47.9% 3.75 US$199,999
2024-08-27 2024-08-27 B Purchase
2.4
Leheny A. Rachel

CHIEF EXECUTIVE OFFICER

Executive Director Large shareholder
1,000 +0.9%
4.19
US$4,190 		1,000 +0.9% 4.19 US$4,190
2024-08-26 2024-08-23 B Purchase
2.9
WILSON ROBERT N
Non-Executive Director
54,000 +17.4%
3.72
US$200,826 		54,000 +17.4% 3.72 US$200,826
2024-08-26 2024-08-23 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
3,000 +29.3%
3.57
US$10,710 		3,000 +29.3% 3.57 US$10,710
2024-08-26 2024-08-23 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
2,000 +4.5%
3.58
US$7,157 		2,000 +4.5% 3.58 US$7,157
2024-08-22 2024-08-21 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
5,000 +12.5%
4.04
US$20,200 		5,000 +12.5% 4.04 US$20,200
2024-07-02 2024-06-28 B Purchase
2.9
WILSON ROBERT N
Non-Executive Director
51,278 +19.8%
3.52
US$180,499 		51,278 +19.8% 3.52 US$180,499
2024-07-01 2024-06-27 B Purchase
2.9
WILSON ROBERT N
Non-Executive Director
8,443 +3.4%
3.23
US$27,305 		8,443 +3.4% 3.23 US$27,305
2024-06-28 2024-06-27 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
5,000 +95.7%
3.22
US$16,100 		5,000 +95.7% 3.22 US$16,100
2024-04-02 2024-04-02 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
3,254 +8.9%
3.90
US$12,691 		3,254 +8.9% 3.90 US$12,691
2024-04-02 2024-04-01 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
746 +2.1%
3.90
US$2,909 		746 +2.1% 3.90 US$2,909
2024-01-25 2024-01-23 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
28,744 +1856.8%
3.70
US$106,410 		28,744 +1856.8% 3.70 US$106,410
2024-01-25 2024-01-23 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
3,920 +22.2%
3.70
US$14,512 		3,920 +22.2% 3.70 US$14,512
2024-01-25 2024-01-23 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
13,184 +91.4%
3.70
US$48,807 		13,184 +91.4% 3.70 US$48,807
2024-01-25 2024-01-23 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
51,032 +80.7%
3.70
US$188,920 		51,032 +80.7% 3.70 US$188,920
2024-01-25 2024-01-23 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
194,472 +80.8%
3.70
US$719,935 		194,472 +80.8% 3.70 US$719,935
2024-01-25 2024-01-23 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
144,676 +24.8%
3.70
US$535,591 		144,676 +24.8% 3.70 US$535,591
2024-01-25 2024-01-23 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
243,356 +34.6%
3.70
US$900,904 		243,356 +34.6% 3.70 US$900,904
2024-01-25 2024-01-23 B Purchase
Sanderling Venture Partners VI LP
Large shareholder
28,744 +1856.8%
3.70
US$106,410 		28,744 +1856.8% 3.70 US$106,410
2024-01-25 2024-01-23 B Purchase
Sanderling Venture Partners VI LP
Large shareholder
3,920 +22.2%
3.70
US$14,512 		3,920 +22.2% 3.70 US$14,512
2024-01-25 2024-01-23 B Purchase
Sanderling Venture Partners VI LP
Large shareholder
13,184 +91.4%
3.70
US$48,807 		13,184 +91.4% 3.70 US$48,807
2024-01-25 2024-01-23 B Purchase
Sanderling Venture Partners VI LP
Large shareholder
51,032 +80.7%
3.70
US$188,920 		51,032 +80.7% 3.70 US$188,920
2024-01-25 2024-01-23 B Purchase
Sanderling Venture Partners VI LP
Large shareholder
194,472 +80.8%
3.70
US$719,935 		194,472 +80.8% 3.70 US$719,935
2024-01-25 2024-01-23 B Purchase
Sanderling Venture Partners VI LP
Large shareholder
144,676 +24.8%
3.70
US$535,591 		144,676 +24.8% 3.70 US$535,591
2024-01-25 2024-01-23 B Purchase
Sanderling Venture Partners VI LP
Large shareholder
243,356 +34.6%
3.70
US$900,904 		243,356 +34.6% 3.70 US$900,904
2023-12-13 2023-12-11 B Purchase
2.9
WILSON ROBERT N
Non-Executive Director
506 +0.3%
3.30
US$1,670 		506 +0.3% 3.30 US$1,670
2023-11-08 2023-11-07 B Purchase
2.4
Leheny A. Rachel

Chief Executive Officer

Executive Director Large shareholder
2,000 +11.9%
3.34
US$6,680 		2,000 +11.9% 3.34 US$6,680
2023-11-08 2023-11-06 B Purchase
3.7
Roberts Eric W

Chief Business Officer

Executive Director Large shareholder
2,400 +7.2%
3.12
US$7,488 		2,400 +7.2% 3.12 US$7,488
2023-11-07 2023-11-06 B Purchase
2.4
Leheny A. Rachel

Chief Executive Officer

Executive Director Large shareholder
2,440 +16.9%
3.12
US$7,615 		2,440 +16.9% 3.12 US$7,615
2023-11-07 2023-11-03 B Purchase
4.2
Hebbar Sudarshan

Chief Medical Officer

Officer
36,000 +360.0%
2.74
US$98,600 		36,000 +360.0% 2.74 US$98,600
2023-11-07 2023-11-03 B Purchase
3.7
Roberts Eric W

Chief Business Officer

Executive Director Large shareholder
11,249 +50.6%
2.83
US$31,846 		11,249 +50.6% 2.83 US$31,846
2023-11-07 2023-11-03 B Purchase
3.7
Roberts Eric W

Chief Business Officer

Executive Director Large shareholder
3,700 +22.3%
2.77
US$10,249 		3,700 +22.3% 2.77 US$10,249
2023-11-06 2023-11-03 B Purchase
2.4
Leheny A. Rachel

Chief Executive Officer

Executive Director Large shareholder
5,000 +53.2%
2.85
US$14,250 		5,000 +53.2% 2.85 US$14,250
2023-11-06 2023-11-03 B Purchase
3.7
Roberts Eric W

Chief Business Officer

Executive Director Large shareholder
5,860 +35.8%
2.70
US$15,828 		5,860 +35.8% 2.70 US$15,828
2023-11-06 2023-11-03 B Purchase
3.7
Roberts Eric W

Chief Business Officer

Executive Director Large shareholder
3,200 +23.9%
2.80
US$8,960 		3,200 +23.9% 2.80 US$8,960
2023-08-29 2023-08-25 B Purchase
3.7
Roberts Eric W

Chief Business Officer

Executive Director Large shareholder
736 +17.3%
3.18
US$2,340 		736 +17.3% 3.18 US$2,340
2023-08-23 2023-08-22 B Purchase
3.7
Roberts Eric W

Chief Business Officer

Executive Director Large shareholder
714 +20.1%
3.27
US$2,335 		714 +20.1% 3.27 US$2,335
Explore more

More insider trading research around CalciMedica Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America